These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

988 related items for PubMed ID: 25292421

  • 21. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
    Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, Nephew KP, Shan B, Burow ME, Wang G.
    Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
    [Abstract] [Full Text] [Related]

  • 22. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.
    Dunlap SM, Chiao LJ, Nogueira L, Usary J, Perou CM, Varticovski L, Hursting SD.
    Cancer Prev Res (Phila); 2012 Jul; 5(7):930-42. PubMed ID: 22588949
    [Abstract] [Full Text] [Related]

  • 23. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun Y, Liang XH, Wang JB, Mei QB, Zhang F, Zhang T.
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [Abstract] [Full Text] [Related]

  • 24. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
    Lee Y, Jung WH, Koo JS.
    Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
    [Abstract] [Full Text] [Related]

  • 25. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R, Badve S, Srour EF, Nakshatri H.
    BMC Cancer; 2010 Aug 06; 10():411. PubMed ID: 20691079
    [Abstract] [Full Text] [Related]

  • 26. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao WH, Liu XY, Wang Y, Yang ZC, Xu HM, Wang HB.
    Oncol Rep; 2013 Jan 06; 29(1):219-25. PubMed ID: 23129177
    [Abstract] [Full Text] [Related]

  • 27. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC, Chang TW, Tseng YL, Lee JC, Chang MC.
    Carcinogenesis; 2014 Jul 06; 35(7):1481-90. PubMed ID: 24403312
    [Abstract] [Full Text] [Related]

  • 28. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze'ev A.
    Mol Cancer Res; 2011 Jan 06; 9(1):14-24. PubMed ID: 21123622
    [Abstract] [Full Text] [Related]

  • 29. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L, Shen D, Li X, Shan X, Wang X, Yan Q, Liu J.
    Oncotarget; 2016 Jan 12; 7(2):1619-32. PubMed ID: 26636541
    [Abstract] [Full Text] [Related]

  • 30. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y, Qin L, Sun T, Wu H, He T, Yang Z, Mo Q, Liao L, Xu J.
    Oncogene; 2017 Feb 23; 36(8):1157-1166. PubMed ID: 27524420
    [Abstract] [Full Text] [Related]

  • 31. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG.
    Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057
    [Abstract] [Full Text] [Related]

  • 32. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
    Deng X, Wu X, Weng H, Song F.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug 13; 32(8):1036-40. PubMed ID: 27412932
    [Abstract] [Full Text] [Related]

  • 33. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
    Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT.
    Cancer Sci; 2011 Apr 13; 102(4):815-27. PubMed ID: 21219539
    [Abstract] [Full Text] [Related]

  • 34. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B.
    Mol Cancer; 2019 Mar 30; 18(1):64. PubMed ID: 30927925
    [Abstract] [Full Text] [Related]

  • 35. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
    Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T.
    J Thorac Oncol; 2011 Jul 30; 6(7):1152-61. PubMed ID: 21597390
    [Abstract] [Full Text] [Related]

  • 36. Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.
    Singh N, Liu G, Chakrabarty S.
    Int J Cancer; 2013 May 01; 132(9):1996-2005. PubMed ID: 23055106
    [Abstract] [Full Text] [Related]

  • 37. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
    Tan JX, Wang XY, Li HY, Su XL, Wang L, Ran L, Zheng K, Ren GS.
    Int J Cancer; 2011 Mar 15; 128(6):1303-15. PubMed ID: 20473947
    [Abstract] [Full Text] [Related]

  • 38. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T, Yuan J, Zhang J, Tian R, Ji W, Zhou Y, Yang Y, Song W, Zhang F, Niu R.
    Oncotarget; 2015 Oct 13; 6(31):30975-92. PubMed ID: 26307676
    [Abstract] [Full Text] [Related]

  • 39. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH, Way TD, Chen WJ.
    Toxicol Appl Pharmacol; 2013 Nov 01; 272(3):746-56. PubMed ID: 23921149
    [Abstract] [Full Text] [Related]

  • 40. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD.
    Cell Signal; 2014 Dec 01; 26(12):2621-32. PubMed ID: 25152370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.